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Abstract Extracts of Viscum album from different host trees (Iscador®Qu, M, P and A) and isolated mistletoe
lectin showed distinct gene-expression profiles using cDNA microarrays. We were able to confirm
that genes of apoptosis, the cell cycle and the immune system were affected by mistletoe preparations and we
also found that signal transduction, cell communication and cancer related pathways were overregulated in the
tested breast cancer (HCC-1937, MCF-7, KPL-1, Mfm-223) and lymphoma cell lines (WSZ-NHL). The effect of a
specific mistletoe extract on a particular cell line was individual, so that the distinction between the reaction of
the cell type and/or the influence of the mistletoe preparation could be used in targeted mistletoe therapy.
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Resumen Perfiles de expresión génica en células tumorales inducidos por extractos  de plantas. Ex-
tractos de Viscum album de diferentes arboles hospedadores (Iscador®Qu, M, P and A) y lectinas
aisladas de muérdago demostraron diferentes patrones de expresión génica utilizando la técnica de microarray.
Pudimos confirmar que genes involucrados en apoptosis, ciclo celular y el sistema inmune fueron afectados por
preparaciones de muérdago. Por otra parte encontramos que vías de señalización, comunicación entre células
y vías relacionadas con cáncer estaban sobreexpresadas en las líneas de cáncer de mama estudiadas (HCC-
1937, MCF-7, KPL-1, Mfm-223) y en la línea de linfoma WSZ-NHL. El efecto de extracto específico de muérda-
go sobre una particular línea celular fue individual, de manera que la distinción entre la reacción del tipo celular
y/o la influencia de la preparación, podrían usarse como blanco en la terapia con extractos de muérdago.
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The cytotoxic effect of Viscum album extracts on
human cancer cells is well documented, and it is known
that cancer cells respond individually to specific mistletoe
preparations, depending on the host tree and the
manufacturing process1-11. The ways in which mistletoe
extracts affect cancer cells have been described for some
cellular mechanisms (apoptosis12-19, cell cycle15, 20, protein
synthesis21, immune modulation21-25, However, the cell
response seems to be very unique and has to be analysed
individually for each cell type. Describing a cancer cell
type according to its corresponding IC50 gives us the
information on whether a cancer cell is sensitive or
resistant to mistletoe extract, but the characteristic, unique
properties of each cell are not taken into account. A
method to characterize the common and individual cellular
alterations is transcriptome analysis. We analyzed
changes of mistletoe extract-treated cells compared to
untreated ones within the 41,000 genes of the Whole
Human Genome chip (Agilent) on the mRNA level. The
obtained gene expression profiles allow us to distinguish
the pathway deregulations caused by either a certain
mistletoe extract or by a specific cancer cell type or
subtype. The gene regulation studies were carried out
with 4 different breast cancer and two lymphoma cell lines.
The aim of the project is to predict the sensitivity of a specific
cancer type to the most efficient mistletoe preparation.
Methods
Viscum album extracts and isolated mistletoe lectin
The mistletoe preparations Iscador® Qu, M, A and P were
provided by Weleda AG, Arlesheim, Switzerland. Isolated
mistletoe lectin (ML I) was a gift of Hiscia AG, Arlesheim,
Switzerland.
Cancer cell lines
Four different breast cancer cell lines, MCF-7, KPL-1, HCC-
1937 and MFM223, and two lymphoma cell lines, WSU-NHL
and DOHH-2, were used.
- - - -
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Cytotoxity assay
All cell lines were tested in regard to their responsiveness to
mistletoe extracts. The IC50 was determined by exposing the
corresponding cancer cells to the appropriate mistletoe extract
in a concentration-dependent manner for 48 hours. The survi-
val of the cells was analysed by determining the mitochondrial
activity (MTT assay).
Microarray experiments
Cell lines were treated for 24 hours with 0.1 mg Iscador
preparation. Then, the mRNA was isolated from cell lysates
of 1-2·106 cells. Only those RNA samples with a 260 nm/280
nm ratio between 1.8 - 2.1 and a 28S/18S ratio within 1.5 - 2
were further processed.
RNA samples (2.5 µg) were reverse-transcribed into double-
stranded cDNA, which was labeled by in vitro transcription
incorporating Cyanine 3-CTP (samples) or Cyanine 5-CTP (re-
ference). Each Cy-3 labeled sample (1 µg) was combined with
the Cy-5 labeled control (1 µg) and hybridized onto Agilent
Whole Human Genome 41k arrays for 17 h at 65 °C.
Hybridized arrays were scanned and the scanned images
were quantified using the Agilent Feature Extraction Software
7.1. Data were excluded for genes that did not have an
expression signal above 200 in either channel.
For each cell line, the cells incubated with the four different
Iscador preparations were compared with untreated ones to
obtain lists of mistletoe affected genes using Genespring.
Then, the obtained gene lists were used to find the pathways
where the regulated genes were significantly overrepresented.
Overrepresentation was declared as significant by t-test if the
p-value for overrepresentation was below 0.01 and within a
pathway if the genelist vs pathway random overlap p-value
was below 0.05.
Each experiment was repeated three times.
Results
Cytotoxicity of Iscador preparations and isolated
mistletoe lectin on cancer cells
In order to achieve an overview of whether mistletoe
extracts and their lectin content affect the chosen cancer
cells and whether the effects were comparable or totally
different, we determined the IC50 value for each cell line
and mistletoe extract (Table 1). In addition to Iscador Qu
(oak-mistletoe), Iscador M (apple tree-mistletoe), Iscador
A (white fir-mistletoe) and Iscador P (pine-mistletoe)
isolated mistletoe lectin, which is known to be the
strongest cytotoxic component of mistletoe extracts, was
tested. Iscador Qu and M are lectin-rich with approxi-
mately 25-50 ng lectin/mg extract, whereas the lectin-poor
Iscador A and P contain only about 1 ng lectin/mg extract.
The lymphoma cells WSU-NHL were most sensitive to
lectin, with an IC50 of 22 ng/ml, followed by Mfm-223 and
DOHH-2. MCF-7 and HCC-1937 are more than 10 times
less responsive to the isolated component. Nevertheless,
the IC50 values of the whole extracts of Iscador Qu, M or A
were all around 0.1 mg/ml for MCF-7 and for Mfm-223
whereas the cells of WSU-NHL, KPL-1 and HCC-1937
reacted similarly to the lectin-rich Iscador Qu and M and
less strongly to the lectin-poor Iscador A (0.3 mg/ml). DOHH-
2 showed the lowest sensitivity to Iscador preparations
compared to the other cell lines. Iscador P did not cause
strong cytotoxic effects on any of the cell lines.
We conclude that lectin is highly cytotoxic. However,
its cytotoxic influence within the multi-component mistletoe
extract was observed in regard to the responsiveness of
cancer cell types only in special cases, but there is not
yet enough evidence to predict these cases reliably
Pathway alterations in cancer cells after Iscador and
lectin treatment
IC50 values quantitatively describe the efficacy of an extract
on a certain cell line in general without referring to cellular
processes in detail. An equal IC50 value does not
correspond to consistently equal molecular responses in
different cell lines. Therefore, cellular mechanisms were
analysed using microarray data at the level of pathways
to characterize cell behaviour in the presence of mistletoe
components. From a total of 188 Keggs pathways in
Genespring, 125 were found to be involved in the action
of mistletoe extracts or mistletoe lectin, causing changes
in the cancer cell mechanism from which the most
important will be selected. In the following Tables (2-5)
TABLE 1.– IC50 values of the mistletoe preparations Iscador Qu, M, A and P and isolated
mistletoe lectin I. The lymphoma (WSU-NHL, DOHH-2) and breast cancer cells (MCF-7,
KPL-1, HCC-1937, MFM223) were exposed for 48 hours to the corresponding test solutions
 Iscador Qu Iscador M Iscador A Iscador P Mistletoe lectin
mg/ml mg/ml mg/ml mg/ml ng/ml
WSU-NHL 0.08 ± 0.01 0.11 ± 0.02 0.19 ± 0.02 1.10 ± 0.01 022 ± 5
DOHH-2 0.30 ± 0.04 0.46 ± 0.10 0.29 ± 0.07 2.70 ± 0.2 094 ± 17
Mfm-223 0.05 ± 0.02 0.12 ± 0.030 0.07 ± 0.03 1.40 ± 0.25 038 ± 3
KPL-1 0.10 ± 0.01 0.12 ± 0.022 0.31 ± 0.06 1.94 ± 0.3 141 ± 29
MCF-7 0.09 ± 0.02 0.12 ± 0.020 0.10 ± 0.02 1.61 ± 0.25 410 ± 59
HCC1937 0.11 ± 0.02 0.10 ± 0.020 0.31 ± 0.02 2.14 ± 1.0 320 ± 73
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TABLE 2.– The cellular metabolisms (carbohydrate metabolism, lipid metabolism, amino acid metabolism, metabolism of
other amino acids, glycan biosynthesis and metabolism, metabolism of cofactors and vitamins) were involved in alterations
in pathways of the breast cancer (MCF-7, KPL-1, HCC-1937, MFM223) and lymphoma cell lines (WSU-NHL, DOHH-2)
after treatment with 0.1 mg Viscum album preparation/ml or mistletoe lectin (at IC50) for 24 hours.
Carbohydrate metabolism
Pathway (number of Treatment HCC-1937 MCF-7 KPL-1 Mfm-223 WSU-NHL DOHH-2
genes/pathway)
Aminosugars Iscador A  +++     
metabolism (50) Iscador P  +++++     
Butanoate Lectin ++++  ++++  
metabolism (66) Iscador Qu     +++  
Citrate cycle (49)  Lectin +++ +++     
Iscador Qu  +++     
Iscador A  ++     
Glyoxylate and Iscador Qu     +++++
dicarboxylate Iscador M     +++++
metabolism (23)   
Pentose phosphate Lectin ++++  +++++ ++++
pathway (43) Iscador Qu     +++  
Iscador M     ++  
Lipid metabolism
Pathway (number of Treatment HCC-1937 MCF-7 KPL-1 Mfm-223 WSU-NHL DOHH-2
genes/pathway)
Biosynthesis of Lectin  +++++ +++++    
steroids (25) Iscador Qu     +++++  
Iscador M     +++++  
Fatty acid elongation Lectin ++++ ++++ +++++    
in mitochondria (14)
Sphingolipid Lectin +++++ ++++ ++++    
metabolism (61)
Synthesis and Iscador Qu  +++++   +++++
degradation of Iscador M     +++++
ketone bodies (13)  
Amino acid metabolism
Pathway (number of Treatment HCC-1937 MCF-7 KPL-1 Mfm-223 WSU-NHL DOHH-2
genes/pathway)
Glycine, serine and Lectin +++++     
threonine Iscador Qu +++    ++++  
metabolism (74) Iscador M     +++  
Methionine Lectin ++++     
metabolism (37) Iscador Qu     +++++  
Iscador M     ++++  
Tryptophan Lectin ++++  +++++    
metabolism  (140) Iscador Qu    +   
Iscador M  ++     
Iscador A  ++     
Iscador P  ++     
Valine, leucine and Iscador Qu +++++ +++++   +++++
isoleucine Iscador M     +++++
biosynthesis (14) Iscador A  +++++    +++++
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the affected pathways were divided into functional groups
such as metabolism, genetic information processing,
environmental information processing, cellular processes
and human diseases, which are further subdivided into
clearly defined pathways.
Metabolism of other amino acids
Pathway (number of Treatment HCC-1937 MCF-7 KPL-1 Mfm-223 WSU-NHL DOHH-2
genes/pathway)
Glutathione Lectin +++++ +++     
metabolism (65) Iscador Qu +++      
Iscador M      ++*
Iscador A   +   ++
Selenoamino acid Lectin +++++     
metabolism (64) Iscador Qu     +++++  
Iscador M     +++++  
Glycan biosynthesis and metabolism 
Pathway (number of Treatment HCC-1937 MCF-7 KPL-1 Mfm-223 WSU-NHL DOHH-2
genes/pathway)
Chondroitin sulfate Lectin  +++++ +++++  
biosynthesis (26) Iscador Qu ++++    +++  
Glycan structures - Lectin  ++++ +++++   
biosynthesis 1 (165) Iscador A ++      
Glycosphingolipid Lectin +++++    
biosynthesis - Iscador Qu +++++    
ganglioseries (26)     
N-Glycan Lectin   +++++  
biosynthesis (65) Iscador A ++      
N-Glycan Lectin   +++++
degradation (24) Iscador Qu +++++      
O-Glycan Lectin  +++++ +++++    
biosynthesis (39)
Metabolism of cofactors and vitamins
Pathway (number of Treatment HCC-1937 MCF-7 KPL-1 Mfm-223 WSU-NHL DOHH-2
genes/pathway)
Nicotinate and Lectin +++++ +++++    
nicotinamide Iscador Qu     ++
metabolism (57)   
One carbon Iscador M     ++++
pool by folate (36) Iscador Qu     +++++  
Iscador M     ++++  
Iscador A  ++++     
Ubiquinone Iscador Qu     +++++
biosynthesis (13) Iscador M     +++++  
(Continuación Table 2)
+++++: ≥ 20% genes overregulated, genelist vs pathway random overlap p-value below 0.1
++++: ≥ 15% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+++: ≥ 10% genes overregulated, genelist vs pathway random overlap p-value below 0.1
++ ≥ 5% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+: ≤ 5% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+ in bold: genelist vs pathway random overlap p-value below 0.001
*: only 1 experiment was carried out
Metabolic pathways
If any cell is subjected to environmental changes by drugs,
very specific pathways are affected; also the basic
metabolism can be overregulated (Table 2). The
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TABLE 3.– The pathways of environmental information processing (membrane transport, signal transduction, signalling
molecules and interaction) were overregulated by the breast cancer (MCF-7, KPL-1, HCC-1937, MFM223) and lymphoma cell
lines (WSU-NHL, DOHH-2) after treatment with 0.1 mg Viscum album preparation/ml or mistletoe lectin (at IC50) for 24 hours.
Pathway (number of
genes/pathway) Treatment HCC-1937 MCF-7 KPL-1 Mfm-223 WSU-NHL DOHH-2
Membrane transport
ABC transporters (67) Lectin ++++ +++++
Iscador A +++ +++++
Signal transduction
Calcium signalling Iscador Qu +*
pathway (292) Iscador M +
Iscador A + +*
Iscador P +
Hedgehog signalling Lectin +++ +++++
pathway  (79) Iscador Qu +++ ++*
Iscador M ++
Iscador A ++*
MAPK signalling Lectin +++++ ++++ +++++ +
pathway (472) Iscador M ++
Iscador A ++
Notch signalling Lectin +++++
pathway (93) Iscador Qu ++
Iscador M ++
TGF-beta signalling Lectin +++++ +++++ +
pathway (137) Iscador Qu +++
Iscador M +
Iscador A ++
Iscador P ++
VEGF signalling Lectin +++
pathway (129) Iscador M ++
Iscador A +++
Wnt signalling Lectin +++ ++++ +++++
pathway (273) Iscador Qu ++
Iscador M ++ + ++*
Iscador A + ++ ++*
Signalling molecules and interaction
Cytokine-cytokine Lectin +++++ +++ +++++ ++
receptor Iscador Qu + + ++
interaction (349) Iscador M + + + ++*
Iscador A + ++
Iscador P + +
 ECM-receptor Lectin +++++ +
interaction (146) Iscador Qu +++ +
Iscador M +* ++*
Iscador A +* ++*
 Regulation of actin Iscador M +
cytoskeleton (394) Iscador A ++ +
Iscador P +
+++++: ≥ 20% genes overregulated, genelist vs pathway random overlap p-value below 0.1
++++: ≥ 15% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+++: ≥ 10% genes overregulated, genelist vs pathway random overlap p-value below 0.1
++ ≥ 5% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+: ≤ 5% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+ in bold: genelist vs pathway random overlap p-value below 0.001
*: only 1 experiment was carried out
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TABLE 4.– The pathways of cellular processes belong to cell growth and death, cell communication, endocrine system,
immune system and behaviour and some are best known to be induced by the breast cancer (MCF-7, KPL-1, HCC-1937,
MFM223) and lymphoma cell lines (WSU-NHL, DOHH-2) after treatment with 0.1 mg Viscum album preparation/ml or
mistletoe lectin (at IC50) for 24 hours.
Pathway (number of
genes/pathway) Treatment HCC-1937 MCF-7 KPL-1 Mfm-223 WSU-NHL DOHH-2
Cell growth and death
Apoptosis (145) Lectin +++++ +++++ +++++
Iscador Qu +
Iscador M +
Iscador A ++
Iscador P +
Cell cycle (183) Lectin +++++
Iscador Qu ++
Iscador M ++
Cell communication
Adherens junction (161) Iscador M ++
Iscador A ++ +
Focal adhesion (363) Iscador M ++ + +
Iscador A ++ +*
Iscador P +
Gap junction (139) Iscador Qu +++
Iscador A ++
Tight junction (229) Iscador M +*
Iscador A ++
Iscador P ++ +*
Endocrine system
Adipocytokine signalling
pathway (125) Lectin +++ ++++ + +
Iscador Qu +++
GnRH signalling Lectin ++++ + +
pathway (165) Iscador A ++
Insulin signalling Lectin +++ + +
pathway (241)
PPAR signalling Lectin +++++ + +
pathway (109) Iscador Qu ++ ++
Iscador M ++
Immune system
Antigen processing Lectin ++++ +++++
and presentation (153) Iscador Qu +++
Iscador M ++++
Iscador A +
Iscador P +
B cell receptor signalling Lectin +++++
pathway (106) Iscador Qu ++ +
Iscador M ++ ++
Iscador P +
Complement and Lectin +++++ +++++ + +
coagulation Iscador Qu ++ +*
cascades (111) Iscador M ++ +++*
Iscador A ++ ++ + ++*
Iscador P ++*
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metabolic pathways of Mfm-223 and DOHH-2 cells were
not induced by mistletoe components whereas the lipid
and amino acid metabolism, as well as the glycan
biosynthesis of HCC-1937, MCF-7 and WSU-NHL were
overregulated in the presence of isolated mistletoe lectin.
In contrast, the whole mistletoe extracts did not produce
remarkable alterations in the metabolic pathways of all
tested cell lines.
The only exception was WSU-NHL, on which Iscador
Qu and M activated the glyoxylate and dicarboxylate
metabolism, the biosynthesis of steroids, the synthesis and
degradation of ketone bodies, the glycine, serine and
threonine metabolism, the methionine metabolism, the
valine, leucine and isoleucine biosynthesis, the seleno-
amino acid metabolism, one carbon pool by folate
metabolism and ubiquinone biosynthesis very strongly and
independently from the other cell lines tested, so that a
selective geneinduction by these two extracts can be
postulated for this cell line.
+++++: ≥ 20% genes overregulated, genelist vs pathway random overlap p-value below 0.1
++++: ≥ 15% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+++: ≥ 10% genes overregulated, genelist vs pathway random overlap p-value below 0.1
++ ≥ 5% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+: ≤ 5% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+ in bold: genelist vs pathway random overlap p-value below 0.001
*: only 1 experiment was carried out
(Continuación Tabla 4)
Fc epsilon RI signalling Lectin +++++
pathway (126) Iscador M +
Iscador A +
Hematopoietic Lectin +++++
cell lineage  (137) Iscador Qu ++
Iscador M +
Iscador A ++ +
Iscador P ++ + +
Natural killer cell mediated Iscador A ++
cytotoxicity (205) Iscador P ++
T cell receptor signalling Lectin +++++ ++++ +++++
pathway (158) Iscador Qu ++ +
Iscador M ++
Iscador A ++
Iscador P ++
Toll-like receptor Lectin +++++ ++++ +
signalling pathway (126) Iscador Qu + +
Iscador M +
Iscador A +
Behaviour
Circadian rhythm (23) Lectin ++++++ +++++ +++++
Iscador Qu ++++
Pathways of environmental information processing
If a cell is exposed to a drug, internal cell processes will
be altered to remove the foreign agent and to reconstitute
the cellular order immediately. Depending on the character
of the cell, different signalling pathways will be induced to
inform the cellular environment and to induce the immune-
response by releasing or activating signal substances. It
has to be considered that the pathways, calcium signalling,
regulation of actin cytoskeleton, MAPK signalling, Wnt
signalling and cytokine-cytokine receptor interaction,
contain from 273 to 472 genes, many more than the
metabolic pathways, and that 20% of the overregulated
genes in these pathways comprise 55 to 95 genes.
In the presence of isolated mistletoe lectin, 9 of the 11
pathways (ABC transporter, Hedgehog signalling pathway,
MAPK signalling pathway, Notch signalling pathway, TGF-
beta signalling pathway, VEGF signalling pathway, Wnt
signalling pathway, Cytokine-cytokine receptor interaction,
ECM-receptor interaction) were mostly strongly overre-
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gulated in the breast cancer cell lines HCC-1937, MCF-7
and KPL-1. The calcium signalling pathway and regulation
of actin cytoskeleton seem to be lectin-independent. The
calcium signalling pathway was induced by Iscador M, A
and P on KPL-1, and Iscador Qu and A on DOHH-2. The
regulation of actin cytoskeleton was affected by Iscador
M on KPL-1, Iscador A on MCF-7 and WSU-NHL and
Iscador P on KPL-1. The most sensitive cell line in all the
environmental information processes was KPL-1. Mfm-
223 and WSU-NHL are well represented under signalling
molecules and interaction so that we conclude that they
were activated on different receptor sides by Iscador Qu,
M or A. Genes of the signal transduction pathways were
targets favoured by Iscador Qu and M.
TABLE 5.– The pathways of human diseases are affected by the breast cancer (MCF-7, KPL-1, HCC-1937, MFM223)
and lymphoma cell lines (WSU-NHL, DOHH-2) after treatment with 0.1 mg Viscum album preparation/ml or
mistletoe lectin (at IC50) for 24 hours.
Pathway (number of Treatment HCC-1937 MCF-7 KPL-1 Mfm-223 WSU-NHL DOHH-2
genes/pathway)
Neurodegenerative disorders 
Neurodegenerative Iscador Qu  ++    +++++*
disorders (66) Iscador A    ++  +++++*
Infectious disease 
Epithelial cell signaling Iscador Qu   ++ +
in Helicobacter pylori Iscador M    +
infection (106) Iscador P   +
Pathogenic Escherichia Iscador Qu +++
coli infection (94) Iscador M     ++  
Iscador A +++      
Iscador P ++      
Cancers
Chronic myeloid Lectin   +++++
leukemia (142) Iscador Qu    +   
Iscador A ++      
Colorectal cancer (153) Lectin  +++ +++++
Iscador Qu  ++
Iscador M  ++
Iscador A  ++  ++
Glioma (112) Lectin   ++++ +
Iscador A ++ ++
Huntington’s Lectin    ++
disease (57) Iscador Qu     +++  
Pancreatic cancer (134) Lectin   ++++    
Iscador A ++
+++++: ≥ 20% genes overregulated, genelist vs pathway random overlap p-value below 0.1
++++: ≥ 15% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+++: ≥ 10% genes overregulated, genelist vs pathway random overlap p-value below 0.1
++ ≥ 5% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+: ≥ 5% genes overregulated, genelist vs pathway random overlap p-value below 0.1
+ in bold: genelist vs pathway random overlap p-value below 0.001
*: only 1 experiment was carried out
Cellular processes
Pathways in this category contain up to 100 genes,
except circadian rhythm with only 23.
It is well documented that apoptosis and cell cycle
are affected by mistletoe extracts. Under the given ex-
perimental conditions (0.1mg extract/ml, 24 hours
incubation time) apoptosis was induced by mistletoe
lectin only on HCC-1937, MCF-7 and KPL-1. Mfm-223
cells became apoptotic under the influence of Iscador
Qu, M, A and P, but not isolated lectin. Cell cycle
deregulation was found in WSU-NHL in the presence of
Iscador Qu and M, and in KPL-1 in the presence of
isolated lectin.
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The immunomodulatory effects of mistletoe extracts
are well known. Interestingly, even cancer cells react with
strong alterations in immune response-related genes,
especially all breast cancer cells tested. Lectin affected
all immune system pathways in HCC-1937, MCF-7 and/
or KPL-1; the Mfm-223 cells were also immune-
responsive, but only to the Iscador preparations, not to
lectin. Whereas the breast cancer cell lines showed
overregulations in the innate and adaptive immune
system, the lymphoma cell lines were affected only in
pathways of the innate immune system, namely in antigen
processing and presentation and complement and
coagulation cascades. It can be concluded that immuno-
modulation is induced in all cell lines by mistletoe compo-
nents or extracts; however the involvement of a specific
pathway is dependent on the individual cancer cell type.
Alterations in pathways of cell communication, the
endocrine system and circadian rhythm are new aspects
involved in describing the action of Viscum album extracts
on cancer cells. Cell communication did not depend on
lectin, which could not overregulate any of the pathways
involved, but was influenced mainly by Iscador A in breast
cancer cell lines and by Iscador A and M in lymphomas.
In contrast, the endocrine system was lectin-dependent
and was induced by lymphoma and breast cancer cells.
Finally, 22-40% of the genes in the circadian rhythm
pathway were changed by isolated mistletoe lectin in
HCC-1937, MCF-7 and KPL-1, so that this aspect has to
be pursued in future studies in vitro as well in vivo.
Human Diseases
Progress in molecular genomics allows the analysis of
disease-related genes which can be influenced by
pharmaceutical agents. Iscador Qu and A activate genes
of neurodegenerative disorders in MCF-7, Mfm-223
moderately and in DOHH-2 extremely. Infectious disease
genes were overregulated in HCC-1937 at the level of
pathogenic Escherichia coli infection and KPL-1 at that
of epithelial cell signalling in Helicobacter pylori infection.
Cancer-related genes were affected by isolated lectin in
KPL-1 only, whereas Iscador Qu, M and A were overre-
gulated in the other three breast cancer cell lines. Iscador
A was the best represented within all cancer pathways
(chronic myeloid leukemia, colorectal cancer, glioma,
Huntington’s disease and pancreatic cancer) and breast
cancer cell lines.
Mistletoe extract-specific genes of
the breast cancer cell lines
From the pathway studies we conclude that the cancer
cell type responds individually to a certain mistletoe extract
which always includes several pathways. However, the
possibility of cellular interactions is of great diversity, so
that common pathways for all treatments and cell lines were
difficult to define within the small cell type population tested.
It is easier to evaluate the specific genes which were
affected by treatment with only one mistletoe extract in
all the breast cancer cell lines HCC-1937, MCF-7, KPL-1
and Mfm-223. We found 1387 specific genes when the
cells were treated with isolated lectin, 177 for Iscador Qu,
194 for Iscador M, 7 for Iscador A and 28 for Iscador P.
Further studies will be undertaken to explain the function
of these mistletoe extract-specific genes.
Conclusion
In summary, mistletoe extracts produced individual
responses in the different cancer cell lines tested.
However, the wide variety in the characteristics of the
different cancer cell types makes classification difficult
with regard to predictable responsiveness to a specific
mistletoe extract. Therefore more cell lines and primary
cancer cells have to be tested.
Isolated mistletoe lectin and the lectin-rich preparations
Iscador Qu and M affected pathways in the breast cancer
cell lines HCC-1937, MCF-7 and KPL-1, and produced
comparable gene-expression profiles in signal trans-
duction, the immune system, cancer and some metabolic
pathways. On the other hand, WSU-NHL and Mfm-223
cells exhibited the lowest IC50 with lectin; nevertheless
only a few pathways were overregulated. Therefore, it
cannot be concluded directly that an activation of many
pathways by one mistletoe extract correlates with stronger
sensitivity. Quite similar is the situation in which a higher
number of overregulated genes represent a better efficacy
of this extract compared to the others. This is absolutely
not true for Iscador A.
All our results are based on only one experimental
condition (0.1 mg mistletoe extract/ml, 24 hour-incubation)
and on the strong statistical restriction in gene analysis.
However, it can be concluded that transcriptome
analyses of mistletoe extracts resulted in clear distinction
of the gene expression profiles between isolated lectin,
the lectin-rich mistletoe extracts (Iscador Qu and M) and
the lectin-poor ones (Iscador A and P). These results can
lead to targeted mistletoe therapies with a selection of
specific, mistletoe-related genes on a microarray chip or
as a set of oligos for qRT-PCR if the different cancer cell
types can be assigned to specific clusters.
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